Linked from

The 17 pages that link to COVID-19, each with the reason it gives.

• DexamethasoneRelated: Dexamethasone benefits some patients with severe disease who require oxygen or ventilation.

• Cytokine stormRelated: Severe cases can involve dysregulated inflammation, though cytokine levels vary and the label is not universal.

• TocilizumabRelated: Tocilizumab is used in selected hospitalized patients with severe COVID-19 and systemic inflammation.

• RemdesivirRelated: COVID-19 is the principal disease for which remdesivir is used.

• HyposmiaRelated: COVID-19 can cause sudden smell loss, sometimes followed by incomplete recovery.

• AgeusiaRelated: Taste loss has been reported during infection, though smell dysfunction often contributes to perceived flavor loss.

• HypogeusiaRelated: Taste impairment can accompany COVID-19, sometimes alongside smell dysfunction.

• OcrelizumabRelated: B-cell depletion can reduce antibody responses to infection and vaccination.